Sport and Self Esteem in Patients Living With HIV
Assessment of Self-esteem According to the Practice of a Sport Activity in a Population of Adults Living With HIV
1 other identifier
observational
1,169
1 country
1
Brief Summary
Adapted athletic activity has shown benefits in patients with certain chronic diseases, including improving fatigue and pain in patients with cancer, and improving the symptoms of severe depression. Among Patients Living with Human Immunodeficiency Virus (PLHIV), sport appears to be less common than for people who do not live with HIV. In fact, 44% of PLHIV in a Swiss cohort (10,500 patients) were inactive in 2014, whereas this percentage was 26% in the general population in Switzerland. We did not find any French data on the prevalence of sports activity among PLHIV. The benefits of sport in PLHIV are numerous: meta-analyzes on interventional studies of aerobic and resistance exercises show a significant improvement in maximum oxygen consumption, muscle strength, percentage of body fat, quality of life and symptoms of depression. An improvement in cognitive function was noted in a randomized study. An Iranian randomized study of 2017 showed an improvement in the CD4 count, after 8 weeks of resistive exercise, but two meta-analyzes of 2016 and 2017 did not find a significant change in CD4 or viral load with physical exercise. On the other hand, several studies have shown that sports practice improves self-esteem. In addition, an Australian randomized study in 2006 showed an improvement in self-efficacy in PLHIVs after a six-month exercise (aerobic and resistance) program. Furthermore, self-esteem (defined as positive self-esteem) is a factor facilitating adherence to antiretroviral therapy. The objective of this descriptive study is to evaluate the prevalence of sports activity in a French adult population infected with HIV and to seek an association with self-esteem. In addition, the investigators will look for an association between sport and fatigue, pain, sleep, lymphocyte T CD4 cell levels, viral load.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 16, 2019
CompletedFirst Posted
Study publicly available on registry
April 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedMarch 9, 2022
March 1, 2022
11 months
April 16, 2019
March 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of self-esteem according to the sport activity of PLHIV
Prevalence of self-esteem (Rosenberg questionnaire) among PLHIV, according to sport activity
six months
Secondary Outcomes (5)
Description of the sporting activity of an adult HIV population
Six months
Description of factors associated with sports activity: fatigue
Six months
Description of factors associated with sports activity: pain
Six months
Description of factors associated with sports activity: sleep
Six months
Search for a correlation between physical activity and HIV activity
6 months
Interventions
Evaluation of physical activity using the International Physical Activity Questionnaire (IPAQ) short version.
Eligibility Criteria
The study population will consist of all HIV-infected patients followed in one of the COREVIH centers of Pays de la Loire participating in this study. Participation in the study will be offered to patients during a usual visit as part of the follow-up of their pathology. The annual number of patients in 2017 being 4300, it is estimated that the number of patients included will be between 1000 and 2000 over 6 months of inclusion with a response rate of at least 50%.
You may qualify if:
- patient with HIV
- aged over 18
- Patient followed by a physician in one of the participating centers of the Regional coordination of the fight against HIV infection (COREVIH) Pays de la Loire
You may not qualify if:
- Refusal or unability to answer the self-questionnaire.
- Patient Under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier le Manslead
- COordination REgionale de lutte contre les IST et le VIH (COREVIH) des Pays de la Loirecollaborator
- Nantes University Hospitalcollaborator
- University Hospital, Angerscollaborator
- Hospital, La Roche sur Yoncollaborator
- Hospital, Saint Nazairecollaborator
- Centre Hospitalier de Choletcollaborator
Study Sites (1)
Centre Hospitalier Le Mans
Le Mans, 72 000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucia Perez, MD
CH Le Mans
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2019
First Posted
April 19, 2019
Study Start
February 1, 2019
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
March 9, 2022
Record last verified: 2022-03